Articles from BIOTECH Patent News (October 1, 2007)

Title	Author	Type	Words
Adams Respiratory files lawsuit against Perrigo for infringement of extended-release guaifenesin patent.			260
Amgen obtains United States patent.			130
Amicus and Shire enter Into $440 million ex-US licensing agreement to develop and commercialize lysosomal storage disorder technology.			965
Applied Research Systems obtains United States patent.		Brief article	105
Bayer obtains United States patent.			39
Biodel receives notice of issuance for United States patent covering lead product candidates.			410
BioNanomatrix announces issuance of nanofluidics patent enabling single molecule whole genome analysis.			521
Bristol-Myers Squibb to acquire Adnexus.			852
Cepheid enters agreement to exclusively license HPV portfolio developed by Quantovir AB.			596
ChemoCentryx demonstrates recently discovered chemokine receptor essential in tumor growth.			950
ChemoCentryx obtains United States patent.			29
ECI Biotech obtains United States patent.			116
Emmaus obtains United States patent.			155
Gendaq obtains United States patent.		Brief article	68
GliaMed obtains United States patent.			45
Idenix restructures to concentrate on HCV and HIV.			541
Katholieke Universiteit Nijmegen obtains United States patent.			151
Korea Kumho obtains United States patent.			272
Massachusetts Institute of Technology obtains United States patent.			117
MedImmune licenses reverse genetics technology to GlaxoSmithKline.			366
Non-surgical stem-cell procedure relieves degenerative joint disease.			424
Novozymes obtains United States patent.			48
Patent for delivery of stem cells to human heart issued to CellCyte Genetics.			405
Strativa Pharmaceuticals to focus on supportive care.			728
Syngenta rights to GA21 in corn reaffirmed by Federal Circuit.			136
United States awards $15 million grant to GeoVax' HIV/AIDS vaccine program.			504
University of Arizona obtains United States patent.			76
University of Maryland obtains United States patent.		Brief article	167